Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 377

1.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group.

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.

PMID:
25042234
[PubMed - in process]
2.

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA.

JAMA. 2014 Jul 23-30;312(4):410-25. doi: 10.1001/jama.2014.8722.

PMID:
25038359
[PubMed - in process]
3.

Histopathological characteristics of buccal mucosa transplants in humans after engraftment to the urethra: A prospective study.

Soave A, Steurer S, Dahlem R, Rink M, Reiss P, Fisch M, Engel O.

J Urol. 2014 Jul 3. pii: S0022-5347(14)03933-0. doi: 10.1016/j.juro.2014.06.089. [Epub ahead of print]

PMID:
24998481
[PubMed - as supplied by publisher]
4.

Structure-based engineering of a minimal porin reveals loop-independent channel closure.

Grosse W, Psakis G, Mertins B, Reiss P, Windisch D, Brademann F, Bürck J, Ulrich A, Koert U, Essen LO.

Biochemistry. 2014 Jul 29;53(29):4826-38. doi: 10.1021/bi500660q. Epub 2014 Jul 15.

PMID:
24988371
[PubMed - in process]
5.

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.

Mocroft A, Reiss P, Rakhmanova A, Banhegyi D, Phillips AN, De Wit S, Ristola M, Lundgren JD, Grarup J, Kirk O; for EuroSIDA in EuroCOORD.

Infection. 2014 Aug;42(4):757-62. doi: 10.1007/s15010-014-0630-4. Epub 2014 Jun 6.

PMID:
24902520
[PubMed - in process]
Free PMC Article
6.

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.

Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin C, El-Sadr W, d'Arminio Monforte A, Phillips A, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren J, Law M; D:A:D study group.

HIV Med. 2014 May 19. doi: 10.1111/hiv.12162. [Epub ahead of print]

PMID:
24840675
[PubMed - as supplied by publisher]
7.

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.

Peters L, Mocroft A, Soriano V, Rockstroh J, Kirkby N, Reiss P, Katlama C, Zakharova N, Flisiak R, Lundgren J; for EuroSIDA in EuroCoord.

HIV Med. 2014 May 11. doi: 10.1111/hiv.12160. [Epub ahead of print]

PMID:
24814468
[PubMed - as supplied by publisher]
8.

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients.

Ingle SM, May MT, Gill MJ, Mugavero MJ, Lewden C, Abgrall S, Fätkenheuer G, Reiss P, Saag MS, Manzardo C, Grabar S, Bruyand M, Moore D, Mocroft A, Sterling TR, D'Arminio Monforte A, Hernando V, Teira R, Guest J, Cavassini M, Crane HM, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

Clin Infect Dis. 2014 Jul 15;59(2):287-97. doi: 10.1093/cid/ciu261. Epub 2014 Apr 24.

PMID:
24771333
[PubMed - in process]
Free PMC Article
9.

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.

Revell A, Boyd M, Wang D, Emery S, Gazzard B, Reiss P, van Sighem A, Montaner J, Lane H, Larder B.

HIV Med. 2014 Aug;15(7):442-8. doi: 10.1111/hiv.12156. Epub 2014 Apr 15.

PMID:
24735474
[PubMed - in process]
10.

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group.

BMC Nephrol. 2014 Mar 25;15:51. doi: 10.1186/1471-2369-15-51.

PMID:
24666792
[PubMed - in process]
Free PMC Article
11.

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.

Zoufaly A, Cozzi-Lepri A, Reekie J, Kirk O, Lundgren J, Reiss P, Jevtovic D, Machala L, Zangerle R, Mocroft A, Van Lunzen J; EuroSIDA in EuroCoord.

PLoS One. 2014 Jan 31;9(1):e87160. doi: 10.1371/journal.pone.0087160. eCollection 2014.

PMID:
24498036
[PubMed - in process]
Free PMC Article
12.

Unraveling the core-shell structure of ligand-capped Sn/SnOx nanoparticles by surface-enhanced nuclear magnetic resonance, Mössbauer, and X-ray absorption spectroscopies.

Protesescu L, Rossini AJ, Kriegner D, Valla M, de Kergommeaux A, Walter M, Kravchyk KV, Nachtegaal M, Stangl J, Malaman B, Reiss P, Lesage A, Emsley L, Copéret C, Kovalenko MV.

ACS Nano. 2014 Mar 25;8(3):2639-48. doi: 10.1021/nn406344n. Epub 2014 Feb 4.

PMID:
24494636
[PubMed - in process]
13.

Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected Persons.

Shepherd L, Souberbielle JC, Bastard JP, Fellahi S, Capeau J, Reekie J, Reiss P, Blaxhult A, Bickel M, Leen C, Kirk O, Lundgren JD, Mocroft A, Viard JP; EuroSIDA in EuroCOORD.

J Infect Dis. 2014 Jul 15;210(2):234-43. doi: 10.1093/infdis/jiu074. Epub 2014 Feb 3.

PMID:
24493824
[PubMed - in process]
14.

Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.

Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N; Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

Clin Infect Dis. 2014 May;58(9):1312-21. doi: 10.1093/cid/ciu038. Epub 2014 Jan 22.

PMID:
24457342
[PubMed - in process]
15.

Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

IeDEA and ART Cohort Collaborations, Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PC, Fox MP, Gandhi NR, González E, Lee CK, Hoffmann CJ, Kambugu A, Keiser O, Ditangco R, Prozesky H, Lampe F, Kumarasamy N, Kitahata M, Lugina E, Lyamuya R, Vonthanak S, Fink V, d'Arminio Monforte A, Luz PM, Chen YM, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. doi: 10.1097/QAI.0b013e3182a39979.

PMID:
24419071
[PubMed - indexed for MEDLINE]
16.

Size and shape dependent photoluminescence and excited state decay rates of diamondoids.

Richter R, Wolter D, Zimmermann T, Landt L, Knecht A, Heidrich C, Merli A, Dopfer O, Reiss P, Ehresmann A, Petersen J, Dahl JE, Carlson RM, Bostedt C, Möller T, Mitric R, Rander T.

Phys Chem Chem Phys. 2014 Feb 21;16(7):3070-6. doi: 10.1039/c3cp54570a. Epub 2014 Jan 7.

PMID:
24398975
[PubMed - in process]
17.

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons.

Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, Morlat P, Moranne O, Smith C, El-Sadr W, Law M, Lundgren JD.

AIDS. 2014 Jan 14;28(2):187-99. doi: 10.1097/QAD.0000000000000042.

PMID:
24361680
[PubMed - in process]
18.

Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda.

Mutwa PR, Boer KR, Rusine J, Muganga N, Tuyishimire D, Schuurman R, Reiss P, Lange JM, Geelen SP.

Pediatr Infect Dis J. 2014 Jan;33(1):63-9. doi: 10.1097/INF.0b013e31829e6b9f.

PMID:
24352189
[PubMed - in process]
19.

An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes.

Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JS, Lane HC, Larder BA; RDI Study Group.

J Antimicrob Chemother. 2014 Apr;69(4):1104-10. doi: 10.1093/jac/dkt447. Epub 2013 Nov 24.

PMID:
24275116
[PubMed - in process]
20.

A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial.

Langebeek N, Sprenger HG, Gisolf EH, Reiss P, Sprangers MA, Legrand J, Richter C, Nieuwkerk PT.

HIV Med. 2014 May;15(5):286-90. doi: 10.1111/hiv.12112. Epub 2013 Nov 11.

PMID:
24215485
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk